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Antimicrobial peptides (AMPs) represent an interesting class of molecules with expanding
biological properties which make them a viable alternative for the development of future
antibiotic drugs. However, for this purpose, some limitations must be overcome: (i) the
poor biostability due to enzymatic degradation; (ii) the cytotoxicity at concentrations
slightly higher than the therapeutic dosages; and (iii) the inefficient delivery to the target
site at effective concentrations. Recently, a derivative of the frog skin AMP esculentin-1a,
named esculentin-1a(1–21)NH2, [Esc(1–21): GIFSKLAGKKIKNLLISGLKG-NH2] has
been found to have a potent activity against the Gram-negative bacterium Pseudomonas
aeruginosa; a slightly weaker activity against Gram-positive bacteria and interesting
immunomodulatory properties. With the aim to optimize the antimicrobial features of
Esc(1–21) and to circumvent the limitations described above, two different approaches
were followed: (i) substitutions by non-coded amino acids, i.e., α-aminoisobutyric acid or
D-amino acids; and (ii) peptide conjugation to gold nanoparticles. In this mini-review, we
summarized the structural and functional properties of the resulting Esc(1–21)-derived
compounds. Overall, our data may assist researchers in the rational design and
optimization of AMPs for the development of future drugs to fight the worldwide problem
of antibiotic resistance.
Keywords: antimicrobial peptide, frog-skin, antibiotic-resistance, D-amino acids, gold nanoparticles,
Pseudomonas aeruginosa
ANTIMICROBIAL PEPTIDES: GENERAL FEATURES
Gene-encoded antimicrobial peptides (AMPs) are evolutionally conserved molecules produced by
almost all living organisms (e.g., bacteria, fungi, higher eukaryotes including humans, Ageitos et al.,
2016). As part of key effectors of the innate immunity, they act as a sudden response against a
multitude of microorganisms before the adaptive immune system comes into action (Boman, 1995;
Hemshekhar et al., 2016). Despite their different length and secondary structure ranging from an
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α-helix, a β-strand, a loop, or an extended conformation in
hydrophobic environments, most of them share an amphipathic
and cationic character at neutral pH (Powers and Hancock,
2003). These two properties are crucial factors, especially for
the mechanism of action of α-helical AMPs, which is generally
based on the perturbation of the target microbial membrane
(Bechinger and Gorr, 2017). More specifically, it consists
in an initial electrostatic interaction between the positively-
charged AMP and the negatively-charged components of the
microbial cell surface, such as lipoteichoic acids in Gram-positive
bacteria, or lipopolysaccharides (LPS) in Gram-negatives, to
finally reach the plasma-membrane. This is then destabilized by
pores formation/local cracks or disintegration in a detergent-
like manner, with consequent cell death (Hall and Aguilar,
2010). Peptide-membrane interaction is the most important step
controlling the selectivity of AMPs towardmicrobial membranes,
which are much richer in anionic phospholipids compared to
those of mammalian cells mainly made of electrically-neutral
(zwitterionic) lipids (Oren et al., 1999). However, peptide-
membrane interaction is dictated not only by the peptide’s
cationicity, but also by other physiochemical parameters of AMPs
encompassing their length, hydrophobicity, amphipathicity,
and helicity (Marín-Medina et al., 2016). Remarkably, unlike
conventional antibiotics, this non-specific mechanism of action
of AMPs very rarely induces resistance (Bechinger and Gorr,
2017) and makes them an interesting class of molecules for
the development of new antimicrobial compounds (Mazer-
Amirshahi et al., 2016). To date, thousands of AMPs have
been characterized from a variety of natural sources as well
as their synthetic derivatives (Liu et al., 2016). Noteworthy, an
increasing number of AMPs has already entered into advanced
stages of clinical trials for topical treatment of different types
of infections. Nevertheless, several limitations can hinder their
development as new therapeutics (da Cunha et al., 2017). Among
them: (i) the cytotoxicity at concentrations slightly higher than
antimicrobial dosing; (ii) the low peptide biostability due to
fast proteolytic degradation; and (iii) the inefficient delivery to
the target site at effective concentrations (Fjell et al., 2012).
Nowadays, thanks to the progress in computational studies and
nanotechnologies, it is possible to circumvent these issues. In
this mini-review article, after a brief overview on amphibian
AMPs and the structural/functional relationships of the frog
skin-derived AMP esculentin-1a(1–21)NH2, Esc(1–21), we will
mainly focus on the principal approaches that have been used to
optimize the biological properties of Esc(1–21): (i) substitution




Among natural storehouses of AMPs, frog skin is one of the
richest (Conlon, 2011b). The expression of genes encoding for
these peptides in dermal serous glands is induced upon contact
with microorganisms (Mangoni et al., 2001); and the produced
AMPs are stored within granules that are released onto the skin
surface in a holocrine mechanism after stress or tissue injury
(König et al., 2015). It was first discovered that amphibian AMPs
do not only protect the host from invading microbial pathogens,
but also regulate the animal’s natural flora (Simmaco et al., 1998);
a trait which has then been confirmed also for human AMPs
(Mangoni et al., 2016). Over the years, since the discovery of
magainins from the skin of Xenopus laevis (Zasloff, 1987), an
increasing number of AMPs has been identified from different
Anuran species (Coccia et al., 2011; Conlon, 2011a). In particular,
from various Rana genera, a large number of AMPs has been
isolated and characterized. On the basis of their common
structural features, they have been classified into several families
encompassing brevinins-1, brevinins-2, nigrocins, temporins,
esculentins-1, and esculentins-2 (Conlon et al., 2004).
Esculentin-1a(1–21)NH2: Synthesis and
Characterization
All members of the esculentin-1 family have a primary structure
composed of 46 amino acids and contain a C-terminal hepta-
membered ring stabilized by a disulfide bridge (Mangoni
et al., 2015). They adopt an amphipathic α-helix structure in
membrane mimicking environments and have a net charge of
+5 at neutral pH (Wang et al., 2016). AMPs belonging to the
esculentin-1 family were initially isolated and purified by reverse-
phase high performance liquid chromatography (RP-HPLC)
from the cutaneous secretions of Pelophylax lessonae/ridibundus
(previously classified as Rana esculenta) specimen (Simmaco
et al., 1993). They have a highly conserved C-terminal half and
differ by only one or two residues in the N-terminal region
(Simmaco et al., 1994). Interestingly, a fragment corresponding
to the 19–46 portion of esculentin-1 peptides was isolated from
one of the HPLC fractions but it was devoid of antimicrobial
activity, probably due to its low net positive charge (+1 vs.
+5 of the full-length AMP, Simmaco et al., 1994). It was then
investigated whether the antimicrobial activity was retained
in the N-terminal half of the molecule. For this reason, a
peptide corresponding to the 1–18 fragment of esculentin-1b was
chemically synthesized and amidated at its C-terminus (Mangoni
et al., 2003). Note that the C-terminal amidation is a common
post-translational modification in linear AMPs from frog skin
(Nicolas and El Amri, 2009). This peptide, named Esc(1–18),
had a comparable antimicrobial activity to that of the full-length
parent esculentin-1, but a lower hemolytic capacity (Mangoni
et al., 2003).
Structurally, Esc(1–18) was found to adopt an α-helix
structure in lipid vesicles mimicking the anionic character
of microbial membranes (Mangoni et al., 2003). It rapidly
killed bacteria (e.g., Escherichia coli) within 15–20 min with
concomitant leakage of cytosolic material, presumably due to the
formation of transient membrane-breakages (Marcellini et al.,
2009). Since the minimum length for a peptide in α-helix
conformation to span a phospholipid bilayer (∼30 Å thick) is
about 20 amino acids, a longer analog named esculentin-1a(1–
21)NH2, Esc(1–21), was further synthesized and characterized
for its biological properties. Esc(1–21) shares the first 20
residues with esculentin-1a (Figure 1) followed by an amidated
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FIGURE 1 | Schematic representation of the amino acids substitutions used to design the Esc(1–21)-analogs and a representative image of the
peptide-conjugated AuNPs.
glycine (Islas-Rodrìguez et al., 2009). It differs from Esc(1–
18) for having (i) an Ile residue at position 11 instead of a
Leu and (ii) three additional C-terminal residues (Leu-Lys-Gly)
which confer it a higher net positive charge at neutral pH
(+6). This should strengthen the electrostatic interaction of
the peptide with the negatively-charged membrane of microbial
cells. Indeed, Esc(1–21) exhibited a higher antimicrobial potency
than Esc(1–18) (Mangoni et al., 2015), especially against Gram-
negative bacteria, e.g., the opportunistic pathogen Pseudomonas
aeruginosa (Gellatly and Hancock, 2013). Esc(1–21) displayed a
quick bactericidal activity within 15 min against both reference
and clinical isolates of P. aeruginosa with concentrations causing
99.9% killing between 0.5 and 1 µM in physiological solution
(Luca et al., 2013). Differently, a weaker activity was detected
against Gram-positive bacteria, as pointed out by the higher
values of minimum inhibitory concentration (MIC) compared to
those recorded toward Gram-negatives (Kolar et al., 2015).
Among other interesting biological features, Esc(1–21) was
found to have the ability (i) to hinder the secretion of the
pro-inflammatory cytokine TNF-α from P. aeruginosa LPS-
stimulated immune cells and (ii) to induce re-epithelialization
of a pseudo-“wound” area generated in a monolayer of
keratinocytes, the most abundant cells in epidermis (Haslam
et al., 2014), at a faster rate than the mammalian AMP LL-37 (Di
Grazia et al., 2015b). This is a relevant matter, which is not shown
by any traditional antibiotic. Note that the healing of an injured
infected tissue does not only require elimination of microbial
pathogens but also the recovery of the tissue integrity along with
its barrier function to prevent pathogens penetration.
Nevertheless, Esc(1–21) is not free from the restrictions
mentioned above. In the following sections, we summarize
the outcome of two different rational approaches employed
to increase the biostability of this peptide and to decrease its
cytotoxicity without compromising its antimicrobial efficacy:
modification of Esc(1–21) by non-coded amino acids i.e.,
α-aminoisobutyric acid (Aib) or D-amino acids, and (ii)
its conjugation to gold nanoparticles (AuNPs). All these
modifications are represented in Figure 1.
The Analog [Aib1,10,18]-Esc(1–21)
The Aib residue is a non-natural amino acid mainly used to
increase the stability of α-helix conformation (Bellanda et al.,
2001). Due to their strong helicogenicity (De Zotti et al., 2012a),
when Aib residues are inserted into the primary structure of
peptides, they are expected to increase their helical content and
to protect them from proteolytic attack (Rink et al., 2010). The
usage of Aib residues is also expected to enlarge the spectrum
of activity of Esc(1–21). This is because a stabilized α-helix
structure is reported to be correlated to the AMPs’ activity
against Gram-positive bacteria (Giangaspero et al., 2001) toward
which Esc(1–21) is not particularly active. The Aib-analog was
synthesized by replacing three amino acids in positions 1, 10, and
18 with Aib residues (Figure 1). This replacement was rationally
designed on the basis of the following considerations: (i) an Aib
residue in position 1 should prevent enzymatic degradation by
aminopeptidases, while the protection of the C-terminus from
carboxypeptidases would not be necessary, due to the presence
of an amidated glycine in Esc(1–21) (Rink et al., 2010); (ii) Aib
residues in positions 10 and 18 should contribute to stabilize
the α-helix structure, due to their stronger α-helix-promoting
activity when placed internally to the primary structure of a
peptide; (iii) according to an ideal α-helix folding of Esc(1–21), it
was possible to identify an hydrophobic face and an hydrophilic
one (Biondi et al., 2016). It is known that in naturally-occurring
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Aib-rich peptides, such as peptaibiotics, Aib residues are located
either within the hydrophobic face or at its boundary with the
hydrophilic one (Toniolo et al., 1994; De Zotti et al., 2012b).
The secondary structure of both Esc(1–21) and its [Aib1,10,18]-
Esc(1–21) was initially investigated by circular dichroism
(CD) (Biondi et al., 2016) in water and two different
membrane-mimicking environments e.g., sodium dodecyl sulfate
(SDS) aqueous solution and trifluoroethanol (TFE). The
results confirmed that both peptides adopted an unordered
conformation in water and an α-helix structure in both SDS
and TFE. However, at increasing concentration of TFE (from
20 to 50%) the helical content in [Aib1,10,18]-Esc(1–21) sharply
increased with respect to the parent peptide. The helical and less
flexible structure of [Aib1,10,18]-Esc(1–21) compared to Esc(1–
21) was also confirmed by 2D-NMR analysis in TFE solution
(Biondi et al., 2016).
Overall, the greater stability and content of α-helix in the
Aib-analog were found to influence the biological properties of
the peptide. More precisely, the Aib-analog gained an overall
higher activity against Gram-positive bacteria, especially those
belonging to Staphylococcus genus [MIC of 2–4 vs. 16–64 µM
of Esc(1–21)] without losing its efficacy against Gram-negative
bacteria and Candida species (Biondi et al., 2016). It is possible
that differences in the composition of the membrane or cell wall
among these microorganisms account for the different activity of
the two esc-peptides against them.
However, a higher α-helicity in [Aib1,10,18]-Esc(1–21) resulted
in increased cytotoxicity against mammalian cell lines (e.g.,
alveolar epithelial cells and keratinocytes). The experimental
data showed that, at the antimicrobial concentrations, Esc(1–21)
and [Aib1,10,18]-Esc(1–21) were harmless to human cells, while
at higher concentrations the cytotoxic effect of the Aib-analog
became clearly evident in comparison with the parent Esc(1–
21) (Biondi et al., 2016). This is consistent with the notion that
both α-helix conformation and its stability are crucial parameters
for mammalian membrane perturbation and cell lysis, likely
assisting the peptide’s penetration into the hydrophobic core of
phospholipids bilayers (Shai and Oren, 1996).
The Analog Esc(1–21)-1c
With the aim to reduce the cytotoxicity and to protect Esc(1–
21) from proteolytic degradation, another analog carrying two
D-amino acids was synthesized: Esc(1–21)-1c. It was obtained
by replacing two L-amino acids i.e., Leu14 and Ser17 with
the corresponding D-amino acid enantiomers (Figure 1). This
diastereomer was rationally designed on the basis of the following
considerations: (i) D-amino acids are known to be “α-helix
breakers” (Grieco et al., 2013) and a reduction in the α-helix
content of the peptide should reduce its propensity to perturb
mammalian membranes leading to cell death (Strahilevitz et al.,
1994); (ii) previous studies on the shorter analog Esc(1–18)
pointed out that in electrically-neutral lipid vesicles the peptide
adopted an α-helix conformation at its C-terminal half. With the
purpose to disrupt at least the first turn of the α-helix expected
to be present in the C-terminal half of Esc(1–21) in mammalian
cell membranes, analogously to what found for Esc(1–18),
replacement of two L-amino acids with the corresponding D-
enantiomers was carried out at position 14 and 17. Note that it
was improbable that the C-terminal tail Gly18-Gly21 of Esc(1–
21) folded in a stable helical conformation.
The stability of both isomers was initially examined in the
presence of 10 and 30% fresh human serum after 24 h incubation
at 37◦C. The data revealed that in comparison with Esc(1–21)
<50% of the diastereomer was degraded (Di Grazia et al., 2015a).
Besides, the presence of these two D-amino acids made the
peptide significantly more resistant to the proteolytic cleavage
caused by both human and bacterial elastases (Cappiello et al.,
2016).
When the structure of the two peptides was analyzed by CD in
lysophosphatidylcholine (LPC), which simulates the zwitterionic
nature of mammalian cell membranes, a loss of α-helix structure
was clearly detected for Esc(1–21)-1c (Di Grazia et al., 2015a). In
contrast with data obtained for the Aib-analog, this diastereomer
was significantly less toxic than Esc(1–21) against mammalian
cells, either circulating cells (e.g., erythrocytes, macrophages) or
epithelial cells. More precisely, its LD50 was higher than 256 µM
in comparison with a LD50 ranging from 64 to 150µM for the all-
L peptide toward macrophages and epithelial cells, respectively
(Di Grazia et al., 2015a; Cappiello et al., 2016). Interestingly,
the introduction of these two residues in the D-configuration
also conferred the peptide: (i) a higher tendency than the all-L
counterpart to kill P. aeruginosa biofilms at concentrations lower
than 25 µM (despite the diastereomer had a slightly reduced
bactericidal activity against the free-living form of this pathogen);
and (ii) a higher “wound” healing activity in vitro (Di Grazia et al.,
2015a).
AuNPs@Esc(1–21)
Amino acids replacement is not the only strategy to increase the
stability of a peptide to proteolytic degradation. Moreover, this
approach does not allow a peptide to overcome biological barriers
(e.g., mucus, skin layers) before reaching the site of infection at
high active concentrations (d’Angelo et al., 2015). A different
biochemical approach to also assist drug delivery at effective
concentrations is given by its conjugation to nanoparticles (NPs).
This would enable not only to protect the drug from the external
environment but also to increase its local concentration.
Among the various NPs produced in recent years, AuNPs have
attracted most attention due to their small size, high solubility,
stability, biocompatibility, and chemical inertness (Connor et al.,
2005). They can diffuse through all layers of human skin
(Williams et al., 2006) and because of their large surface area,
they can be functionalized with a high number of molecules
(Yih and Al-Fandi, 2006; Pietro et al., 2016; Soica et al., 2016).
Nevertheless, only a limited number of studies has been reported
to date on the effects of conjugation of AMPs to AuNPs (Rai
et al., 2016). By using Esc(1–21) as a model peptide, it was
demonstrated for the first time how a chemical conjugation of an
AMP via polyethylene glycol (PEG) linker to AuNPs increases its
antimicrobial activity while retaining its mode of action without
becoming toxic to human keratinocytes. AuNPs were synthetized
by the citrate reduction of gold and stabilized with a bifunctional
PEG bearing a thiol and a carboxylic group. The PEG was
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• Same activity against Gram-
negative bacteria and yeasts
• Higher activity against Gram-
positive bacteria
• Higher cytotoxicity against
mammalian cells
Esc(1–21)-1c • Lower α-helical
content in the
secondary structure
• Higher resistance to
proteolytic degradation
• Slightly lower activity against
the planktonic form of
P. aeruginosa
• Higher activity against the
sessile form of P. aeruginosa
• Lower cytotoxicity against
mammalian cells
• Greater efficacy in promoting
migration of human lung
epithelial cells
AuNPs@Esc(1–21) • Conjugation to




• Higher activity against both
planktonic and sessile forms
of P. aeruginosa








*with respect to Esc(1–21).
attached to the AuNPs via a gold-thiol bond (AuNPs@PEG),
while the carboxylic group was used for further derivatization
with the peptide via carbodiimide-mediated coupling (Casciaro
et al., 2017).
Remarkably, the obtained AuNPs@Esc(1–21) resulted to be
more active than the free peptide against both planktonic
and sessile forms of P. aeruginosa. This was indicated by the
corresponding minimal concentrations causing 50% killing of
both bacterial phenotypes which were found to be ∼15-fold
lower than those of the free Esc(1–21). This is presumably
due to the higher concentration of peptide molecules at
the site of bacterium-NP contact, as visualized by electron
microscopy images which evidenced how these AuNPs@Esc(1–
21) form clusters at various points on the bacterial surface with
disruption of the membrane and leakage of cytosolic material.
Otherwise, our unconjugated bare-AuNPs did not show any anti-
pseudomonal activity and were not detected around bacterial
cells (Casciaro et al., 2017). This is in line with the findings that
non-functionalized AuNPs are harmless also to other bacterial
pathogens (Williams et al., 2006) and suggests that the cationic
AMP represents the driving force allowing AuNPs@Esc(1–21)
to reach the target site at high concentration. In addition,
AuNPs@Esc(1–21) were resistant to proteolytic degradation
preserving their antibacterial activity 2 h after treatment with
trypsin (Casciaro et al., 2017). Finally, AuNPs@Esc(1–21) were
harmless to keratinocytes and retained the peptide’s capability
to stimulate migration of keratinocytes in a pseudo-“wound”
healing assay. Altogether these findings make AuNPs@Esc(1–
21) an attractive nano-formulation for topical treatment of skin
infections (Casciaro et al., 2017).
CONCLUSIONS
Antibiotic-resistant microbial infections cause thousands of
deaths per year worldwide and this necessitates the discovery
of new compounds to counter them. In this scenario, AMPs
represent promising anti-infective molecules with expanding
properties. However, their low biostability, cytotoxic effect
at concentrations higher than therapeutic dosages and the
difficulty in reaching target sites at active concentration, remain
disadvantages that must be overcome. In this mini-review, by
using Esc(1–21) as a reference, we have summarized how (i)
substitution of natural amino acids by non-coded residues as
well as (ii) peptide conjugation to AuNPs represent encouraging
methodologies to optimize the biological properties of an AMP.
Each synthetized analog/compound showed its own peculiarities
according to its structural features (Table 1). Overall, the two
different approaches should serve as an example to assist and to
ameliorate the development of new peptide-based formulation
for an efficient treatment of different types of infectious diseases.
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